ODESSA, Texas (KMID/KPEJ) – Dr. Manohar Angirekula, Dr. Adam Farber, and Dr. Fernando Boccalandro have successfully implanted the first “Watchman FLX” Pro Device at Medical Center Hospital.
The trial data provided clinical evidence indicating that LAAC with the WATCHMAN FLX device is safe and superior to oral anticoagulation (OAC) therapy for reducing the risk of long-term bleeding ...
which demonstrated the effectiveness and safety of the Watchman FLX device. The trial showed that the device is not only comparable in efficacy to oral anticoagulants in preventing stroke and ...
WATCHMAN FLX™ Pro Left Atrial Appendage Closure (LAAC) device, enhancing stroke prevention options for patients with non-valvular ...